Heron Therapeutics, Inc a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, announced that the U.S. Food and Drug Administration (FDA) has approved APONVIE (aprepitant) injectable emulsion, for intravenous use for the prevention of postoperative nausea and vomiting (PONV) in adults.
- Read more about FDA approves Aponvie against Postoperative Nausea and Vomiting
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2022/fda-approves-aponvie-against-postoperative-nausea-and-vomiting
No comments:
Post a Comment